Longitudinal Evaluation and Real-world Evidence of NT201

NCT05222607 · clinicaltrials.gov ↗

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Corporate Management Decision

Conditions

Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face

Interventions

DRUG: IncobotulinumtoxinA

Sponsor

Merz North America, Inc.